O	0	1	A
O	2	12	randomized
O	13	23	controlled
O	24	29	trial
O	30	32	of
O	33	34	a
B-intervention	35	43	wearable
I-intervention	44	54	technology
I-intervention	54	55	-
I-intervention	55	60	based
I-intervention	61	73	intervention
O	74	77	for
O	78	88	increasing
O	89	97	moderate
O	98	100	to
O	101	109	vigorous
O	110	118	physical
O	119	127	activity
O	128	131	and
O	132	140	reducing
O	141	150	sedentary
O	151	159	behavior
O	160	162	in
O	163	169	breast
O	170	176	cancer
O	177	186	survivors
O	186	187	:
O	188	191	The
O	192	200	ACTIVATE
O	201	206	Trial
O	206	207	.

O	208	211	The
O	212	220	benefits
O	221	223	of
O	224	226	an
O	227	233	active
O	234	243	lifestyle
O	244	249	after
O	250	251	a
O	252	258	breast
O	259	265	cancer
O	266	275	diagnosis
O	276	279	are
O	280	284	well
O	285	295	recognized
O	295	296	,
O	297	300	but
O	301	304	the
O	305	313	majority
O	314	316	of
O	317	326	survivors
O	327	330	are
O	331	345	insufficiently
O	346	352	active
O	352	353	.

O	354	357	The
O	358	366	ACTIVATE
O	367	372	Trial
O	373	381	examined
O	382	385	the
O	386	394	efficacy
O	395	397	of
O	398	400	an
O	401	413	intervention
O	414	415	(
O	415	418	use
O	419	421	of
O	422	425	the
O	426	432	Garmin
O	433	440	Vivofit
O	441	442	2
O	443	451	activity
O	452	459	monitor
O	460	467	coupled
O	468	472	with
O	473	474	a
O	475	485	behavioral
O	486	494	feedback
O	495	498	and
O	499	503	goal
O	503	504	-
O	504	511	setting
O	512	519	session
O	520	523	and
O	524	525	5
O	526	535	telephone
O	535	536	-
O	536	545	delivered
O	546	552	health
O	553	561	coaching
O	562	570	sessions
O	570	571	)
O	572	574	to
O	575	583	increase
O	584	592	moderate
O	593	595	to
O	596	604	vigorous
O	605	613	physical
O	614	622	activity
O	623	624	(
O	624	628	MVPA
O	628	629	)
O	630	633	and
O	634	640	reduce
O	641	650	sedentary
O	651	659	behavior
O	660	662	in
O	663	669	breast
O	670	676	cancer
O	677	686	survivors
O	686	687	.

O	688	692	This
O	693	703	randomized
O	704	714	controlled
O	715	720	trial
O	721	730	recruited
B-total-participants	731	733	83
B-eligibility	734	742	inactive
I-eligibility	742	743	,
I-eligibility	744	758	postmenopausal
I-eligibility	759	764	women
I-eligibility	765	774	diagnosed
I-eligibility	775	779	with
I-eligibility	780	785	stage
I-eligibility	786	787	I
I-eligibility	787	788	-
I-eligibility	788	791	III
I-eligibility	792	798	breast
I-eligibility	799	805	cancer
I-eligibility	806	809	who
I-eligibility	810	813	had
I-eligibility	814	823	completed
I-eligibility	824	831	primary
I-eligibility	832	841	treatment
O	841	842	.

O	843	855	Participants
O	856	860	were
O	861	869	randomly
O	870	878	assigned
O	879	881	to
O	882	885	the
O	886	898	intervention
O	899	904	group
O	905	907	or
O	908	910	to
O	911	914	the
B-control	915	922	control
I-control	923	928	group
O	928	929	,
O	930	933	and
O	934	937	the
O	938	950	intervention
O	951	954	was
O	955	964	delivered
O	965	969	over
O	970	971	a
O	972	974	12
O	974	975	-
O	975	979	week
O	980	986	period
O	986	987	.

O	988	992	MVPA
O	993	996	and
O	997	1006	sedentary
O	1007	1015	behavior
O	1016	1020	were
O	1021	1029	measured
O	1030	1034	with
O	1035	1044	Actigraph
O	1045	1048	and
O	1049	1057	activPAL
O	1058	1072	accelerometers
O	1073	1075	at
O	1076	1084	baseline
O	1085	1086	(
O	1086	1088	T1
O	1088	1089	)
O	1090	1093	and
O	1094	1096	at
O	1097	1100	the
O	1101	1104	end
O	1105	1107	of
O	1108	1111	the
O	1112	1124	intervention
O	1125	1126	(
O	1126	1128	T2
O	1128	1129	)
O	1129	1130	.

O	1131	1140	Retention
O	1141	1143	in
O	1144	1147	the
O	1148	1153	trial
O	1154	1157	was
O	1158	1162	high
O	1162	1163	,
O	1164	1168	with
B-total-participants	1169	1171	80
O	1172	1173	(
O	1173	1175	96
O	1175	1176	%
O	1176	1177	)
O	1178	1180	of
O	1181	1193	participants
O	1194	1204	completing
O	1205	1207	T2
O	1208	1212	data
O	1213	1223	collection
O	1223	1224	.

O	1225	1227	At
O	1228	1230	T2
O	1230	1231	,
O	1232	1237	there
O	1238	1241	was
O	1242	1243	a
O	1244	1255	significant
O	1256	1263	between
O	1263	1264	-
O	1264	1269	group
O	1270	1280	difference
O	1281	1283	in
B-outcome	1284	1288	MVPA
O	1289	1290	(
O	1290	1292	69
O	1293	1296	min
O	1296	1297	/
O	1297	1299	wk
O	1299	1300	;
O	1301	1303	95
O	1303	1304	%
O	1305	1307	CI
O	1308	1309	=
O	1310	1312	22
O	1312	1313	-
O	1313	1316	116
O	1316	1317	)
O	1318	1326	favoring
O	1327	1330	the
O	1331	1343	intervention
O	1344	1349	group
O	1349	1350	.

O	1351	1354	The
O	1355	1360	trial
O	1361	1369	resulted
O	1370	1372	in
O	1373	1374	a
O	1375	1388	statistically
O	1389	1400	significant
O	1401	1409	decrease
O	1410	1412	in
O	1413	1417	both
B-outcome	1418	1423	total
I-outcome	1424	1431	sitting
I-outcome	1432	1436	time
I-outcome	1437	1440	and
I-outcome	1441	1450	prolonged
I-outcome	1451	1456	bouts
I-outcome	1457	1458	(
I-outcome	1458	1459	â‰¥
I-outcome	1459	1461	20
I-outcome	1462	1465	min
I-outcome	1465	1466	)
I-outcome	1467	1469	of
I-outcome	1470	1477	sitting
O	1477	1478	,
O	1479	1483	with
O	1484	1491	between
O	1491	1492	-
O	1492	1497	group
O	1498	1508	reductions
O	1509	1511	of
O	1512	1514	37
O	1515	1518	min
O	1518	1519	/
O	1519	1520	d
O	1521	1522	(
O	1522	1524	95
O	1524	1525	%
O	1526	1528	CI
O	1529	1530	=
O	1531	1532	-
O	1532	1534	72
O	1535	1537	to
O	1538	1539	-
O	1539	1540	2
O	1540	1541	)
O	1542	1545	and
O	1546	1548	42
O	1549	1552	min
O	1552	1553	/
O	1553	1554	d
O	1555	1556	(
O	1556	1558	95
O	1558	1559	%
O	1560	1562	CI
O	1563	1564	=
O	1565	1566	-
O	1566	1568	83
O	1569	1571	to
O	1572	1573	-
O	1573	1574	2
O	1574	1575	)
O	1575	1576	,
O	1577	1589	respectively
O	1589	1590	,
O	1591	1599	favoring
O	1600	1603	the
O	1604	1616	intervention
O	1617	1622	group
O	1622	1623	.

O	1624	1631	Results
O	1632	1636	from
O	1637	1640	the
O	1641	1649	ACTIVATE
O	1650	1655	Trial
O	1656	1663	suggest
O	1664	1668	that
O	1669	1672	the
O	1673	1676	use
O	1677	1679	of
O	1680	1688	wearable
O	1689	1699	technology
O	1700	1708	presents
O	1709	1711	an
O	1712	1723	inexpensive
O	1724	1727	and
O	1728	1736	scalable
O	1737	1748	opportunity
O	1749	1751	to
O	1752	1762	facilitate
O	1763	1767	more
O	1768	1774	active
O	1775	1785	lifestyles
O	1786	1789	for
O	1790	1796	cancer
O	1797	1806	survivors
O	1806	1807	.

O	1808	1815	Whether
O	1816	1818	or
O	1819	1822	not
O	1823	1827	such
O	1828	1836	wearable
O	1837	1847	technology
O	1847	1848	-
O	1848	1853	based
O	1854	1867	interventions
O	1868	1871	can
O	1872	1878	create
O	1879	1890	sustainable
O	1891	1901	behavioral
O	1902	1908	change
O	1909	1915	should
O	1916	1918	be
O	1919	1922	the
O	1923	1930	subject
O	1931	1933	of
O	1934	1940	future
O	1941	1949	research
O	1949	1950	.
